4.7 Review

COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Review Immunology

Effectiveness of on-site influenza vaccination strategy in Italian healthcare workers: a systematic review and statistical analysis

Francesco Paolo Bianchi et al.

Summary: International Public Health Organizations recommend on-site influenza vaccination for healthcare workers (HCWs) to improve vaccination coverage. Studies in Italy have shown that on-site vaccination services significantly increase vaccine uptake, although the target of 75% coverage among HCWs has not been achieved.

EXPERT REVIEW OF VACCINES (2023)

Article Immunology

Patients with IBD have a more cautious attitude towards COVID-19 vaccination

Shurong Hu et al.

Summary: This study investigated the awareness, willingness to vaccinate, and influencing factors of COVID-19 vaccine in inflammatory bowel disease (IBD) patients. The results showed that IBD patients had a more cautious attitude towards COVID-19 vaccination, which may lead to a higher rate of vaccine hesitancy. Further efforts should be made to protect IBD patients from COVID-19 infections and achieve adequate vaccination coverage.

FRONTIERS IN IMMUNOLOGY (2023)

Review Pediatrics

The epidemiology of inflammatory bowel disease: Clues to pathogenesis?

Stephen M. M. Borowitz

Summary: Inflammatory bowel disease (IBD) has been increasing globally over the past century and has spread to developing countries. Genetic factors and environmental exposures both contribute to the development of IBD. Urban areas and good domestic hygiene during childhood are associated with a higher risk of IBD. Migration from high to low incidence areas affects the risk of developing IBD. Early environmental exposures may trigger IBD in genetically susceptible individuals, but specific triggers remain unknown.

FRONTIERS IN PEDIATRICS (2023)

Article Medicine, General & Internal

Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy

Gian Paolo Caviglia et al.

Summary: This study investigated the clinical characteristics and epidemiological changes of inflammatory bowel diseases (IBD) in the Healthcare District Bra. The prevalence and incidence of IBD have increased significantly over the past two decades, highlighting the need for specific interventions to improve patient management and resource allocation.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Gastroenterology & Hepatology

Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD)

Mariabeatrice Principi et al.

Summary: This study presents data on the safety of anti-SARS-CoV-2 vaccination in a cohort of inflammatory bowel disease (IBD) patients. About 45% of patients experienced at least one side effect, all of which were mild and short-lived. Female sex, younger age, seroconversion, and comorbidity were significantly associated with adverse events.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Public, Environmental & Occupational Health

Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis

Stephanie Zintel et al.

Summary: This systematic review and meta-analysis found lower vaccination intentions among women than men in the context of COVID-19. This difference was consistent across multiple countries and more pronounced in samples of healthcare workers.

JOURNAL OF PUBLIC HEALTH-HEIDELBERG (2023)

Article Infectious Diseases

Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease

Timothy Ford et al.

Summary: Patients with Inflammatory Bowel Disease (IBD) have a low uptake of vaccinations, therefore early assessment and immunization are important to improve vaccination rates.

BMC INFECTIOUS DISEASES (2022)

Editorial Material Gastroenterology & Hepatology

High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease

Trevor L. Schell et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Diseases at a Diverse Safety Net Hospital

Howard S. Herman et al.

Summary: This study surveyed patients with inflammatory bowel disease (IBD) to assess their attitudes towards COVID-19 vaccination, particularly among underrepresented minorities (URMs). The results showed that URM patients had higher vaccine hesitancy, with younger age, Hispanic, and Black patients being more hesitant.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Gastroenterology & Hepatology

COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease

Kofi Clarke et al.

Summary: Over one-third of patients with inflammatory bowel disease (IBD) expressed hesitancy towards the COVID-19 vaccine, primarily due to concerns about its safety and efficacy. Factors associated with hesitancy included younger age, previous vaccine refusal, and earlier date of survey administration. Targeted education is needed to improve COVID-19 vaccine uptake in this population.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Gastroenterology & Hepatology

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Kimberly N. Weaver et al.

Summary: The severe acute respiratory syndrome coronavirus 2 vaccine is safe and well tolerated among individuals with inflammatory bowel disease (IBD) with low rates of adverse events and flare-ups.

INFLAMMATORY BOWEL DISEASES (2022)

Article Rheumatology

COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis

Jessica Widdifield et al.

Summary: This study assessed the uptake of COVID-19 vaccines among individuals with immune-mediated inflammatory diseases (IMIDs) and the general population in Ontario. The results showed that IMID patients had higher vaccination rates compared to the general population, particularly among those with stronger immune responses.

JOURNAL OF RHEUMATOLOGY (2022)

Article Gastroenterology & Hepatology

Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey

Benedicte Caron et al.

Summary: Approximately half of patients with inflammatory bowel disease are willing to receive the COVID-19 vaccine, citing reasons such as vaccine efficacy, social responsibility, herd immunity, and the desire to return to normal life. Reasons for vaccine hesitancy include unknown long-term safety, risk of adverse reactions, and concerns about the speed of vaccine development. Despite some concerns, patients with inflammatory bowel disease recognize the necessity of being vaccinated against COVID-19.

DIGESTIVE DISEASES AND SCIENCES (2022)

Review Gastroenterology & Hepatology

Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis

Deepak James et al.

Summary: COVID-19 vaccination in patients with IBD appears to be safe, with only mild adverse events reported. The incidence of flares of IBD and severe adverse events requiring hospitalization was low.

DIGESTIVE AND LIVER DISEASE (2022)

Editorial Material Biotechnology & Applied Microbiology

Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward COMMENT

Lukman Lawal et al.

Summary: Disparities in COVID-19 vaccine coverage across the globe have revealed inequalities in global healthcare. While more than half of the population in developed countries have been fully vaccinated, only a small percentage of the African population has received even a single dose, significantly falling short of global vaccination targets. Additionally, many low and middle income African countries lack the capacity, infrastructure, logistics, and financial resources for mass vaccination efforts. This paper focuses on the causes and implications of low COVID-19 vaccine coverage in Africa and the global community, as well as discusses strategies for restructuring and strengthening COVID-19 vaccination in Africa.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Review Medicine, General & Internal

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)

Aleksandra Kubas et al.

Summary: Vaccination against COVID-19 is considered safe and effective for patients with IBD, although further research is needed to understand its safety in special populations. The willingness to receive the vaccine among IBD patients is conflicting, with concerns about effectiveness and safety being the most common reasons for hesitancy.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease

Judith Wellens et al.

Lancet Gastroenterology & Hepatology (2022)

Article Gastroenterology & Hepatology

An Updated Comparative Study on the Impact of COVID-19 Infection and Vaccination in Patients with Inflammatory Bowel Disease and Irritable Bowel Syndrome

Nicole Sciberras et al.

Summary: This study compared patients with inflammatory bowel disease (IBD) on immunomodulation and patients with irritable bowel syndrome (IBS) in terms of swabbing rates, vaccine uptake, COVID-19 infection, hospitalization rates, and outcomes. The results showed that IBD patients underwent more COVID-19 tests and had a higher vaccination rate. Consistent with international studies, IBD patients were not at an increased risk of worse outcomes from COVID-19 infection compared to non-IBD patients.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2022)

Review Immunology

COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis

Francesco Paolo Bianchi et al.

Summary: Pregnant and breastfeeding women show a high level of vaccine hesitancy towards COVID-19 vaccines, mainly due to lack of information, safety concerns, and fear of adverse events.

EXPERT REVIEW OF VACCINES (2022)

Review Public, Environmental & Occupational Health

Vaccine equity in low and middle income countries: a systematic review and meta-analysis

Huda Ahmed Ali et al.

Summary: This systematic review examines the factors contributing to inequality in vaccination coverage and impact. The study highlights the role of wealth disparity in driving these disparities, as well as the influence of gender, education, and geographic access. The findings emphasize the need for targeted vaccination strategies to address these inequities and improve coverage.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2022)

Review Gastroenterology & Hepatology

Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review

Elham Tabesh et al.

Summary: This study evaluated the benefits and side effects of different vaccines in patients with inflammatory bowel disease (IBD). The findings showed that vaccination can protect these patients from serious complications and mortality with minor side effects, and booster doses are recommended.

BMC GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease

Eva Zhang et al.

Summary: This study aims to explore the attitudes, concerns, and influence of different sources of information on COVID-19 vaccine uptake in inflammatory bowel disease (IBD) patients. The results showed that vaccine hesitancy in IBD patients is low, but concerns about the safety of vaccination in pregnancy and causing an IBD flare negatively affect vaccine uptake. Healthcare providers are the most trusted source of information for vaccination.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy

Rania Selim et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study

Yubin Cao et al.

Summary: This study found that patients with inflammatory bowel disease (IBD) have concerns about the safety of COVID-19 vaccination, leading to low vaccination rates. However, the adverse reactions after vaccination were mild, and IBD and its medications did not increase the risk of adverse reactions.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2022)

Article Medicine, General & Internal

Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases

Han Hee Ryu et al.

Summary: This study found that vaccination rates among patients with IBD were low, and knowledge about vaccination was insufficient. Recommendations from physicians were found to significantly improve vaccination rates.

MEDICINE (2021)

Review Immunology

Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis

Francesco Paolo Bianchi et al.

Summary: The meta-analysis revealed suboptimal immunization coverage for recommended vaccines among splenectomized patients. Most studies indicated a lack of adherence to international guidelines by healthcare workers, suggesting a need for better education. Efforts should be made by public health professionals to increase vaccination coverage in this at-risk patient population.

EXPERT REVIEW OF VACCINES (2021)

Review Health Care Sciences & Services

Disparities in H1N1 Vaccination Rates: a Systematic Review and Evidence Synthesis to Inform COVID-19 Vaccination Efforts

Chelsea K. Ayers et al.

Summary: Data suggest disparities in H1N1 vaccine uptake among different racial/ethnic and socioeconomic groups, with African American/Black, Latino, and low-SES participants having lower vaccination rates. Efforts to address these disparities in COVID-19 vaccine uptake should focus on improving accessibility and convenience, providing accurate vaccine information through trusted stakeholders, and addressing concerns about vaccine safety and efficacy, especially in minority and low-SES communities.

JOURNAL OF GENERAL INTERNAL MEDICINE (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Letter Gastroenterology & Hepatology

Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey

Federica Crispino et al.

INFLAMMATORY BOWEL DISEASES (2021)

Letter Gastroenterology & Hepatology

Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease

Edoardo G. Giannini et al.

JOURNAL OF CROHNS & COLITIS (2021)

Review Health Care Sciences & Services

The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: Vaccination Refusal Could Prolong the War of This Pandemic A Systematic Review

Addisu Dabi Wake

Summary: The study found varying levels of willingness to receive the COVID-19 vaccine globally, with multiple factors influencing this willingness. Health education is needed to improve community willingness to receive the vaccine.

RISK MANAGEMENT AND HEALTHCARE POLICY (2021)

Review Medicine, Research & Experimental

Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review

Gbadebo Collins Adeyanju et al.

Summary: The review identified individual determinants of influenza vaccine hesitancy among pregnant women in Europe, including psychological aspects, doubts about vaccine effectiveness, lack of knowledge, and influence of healthcare workers and personal antivaccine sentiments. Strategies incorporating increased knowledge, valid risk judgment, and improved dialogue between healthcare providers and pregnant women are important for promoting vaccination uptake.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2021)

Article Gastroenterology & Hepatology

Errors in the care of inflammatory bowel disease patients: Errata Study

Maria Jose Casanova et al.

GASTROENTEROLOGIA Y HEPATOLOGIA (2020)

Article Gastroenterology & Hepatology

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

Cristina Bezzio et al.

Article Gastroenterology & Hepatology

Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?

Giovanni Monteleone et al.

JOURNAL OF CROHNS & COLITIS (2020)

Article Biotechnology & Applied Microbiology

Influenza vaccination coverage among splenectomized patients: an Italian study on the role of active recall in the vaccination compliance

Francesco Paolo Bianchi et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Article Public, Environmental & Occupational Health

Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease — United States, 2015 and 2016

Fang Xu et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Review Multidisciplinary Sciences

Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis

Pietro Amedeo Modesti et al.

PLOS ONE (2016)